Change the bylaws of yesterday to reflect the faces of ID today. Vote YES when you receive your ballot in December to change IDSA’s Nominations Committee to a new Leadership Development Committee.
Before patients receive intravenous (IV) antimicrobial infusion therapy outside of the hospital – whether at home, a doctor’s office or a skilled nursing facility – an infectious diseases (ID) specialist should review the order to ensure the most appropriate treatment, suggest updated guidelines released by the Infectious Diseases Society of America (IDSA).
News of continued cutbacks at one of what is already a limited number of companies conducting antibiotic research and development threatens access to a critical medicine and further validates a critical need for government-led incentives that both reward and support work towards a robust, renewable antibiotic supply.
A panel of experts was convened by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) to update the 2010 clinical practice guideline on Clostridium difficile infection (CDI) in adults. The update, which has incorporated recommendations for children (following the adult recommendations for epidemiology, diagnosis, and treatment), includes significant changes in the management of this infection and reflects the evolving controversy over best methods for diagnosis. This guideline updates recommendations regarding epidemiology, diagnosis, treatment, infection prevention, and environmental management.
The ID/HIV Career Center is your link to professional opportunities across the country where top employers post infectious diseases specific job opportunities. Find or or post a job today.Learn More
Save the date for IDWeek 2019, the combined annual meeting of IDSA, SHEA, HIVMA, and PIDS, which will be held October 2-6, 2019 in Washington DC.
IDWeek 2018 attendees: To access session recordings, claim CME/CPE/MOC credits, or obtain certificate of attendance, click here.
Clinical Infectious Diseases (CID), one of the most heavily cited journals in the fields of infectious diseases and microbiology, publishes articles on diverse topics in infectious diseases, with a focus on clinical practice.
Founded in 1904, The Journal of Infectious Diseases (JID) is the premier global publication for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms.
Open Forum Infectious Diseases (OFID) provides a global forum for the publication of clinical, translational, and basic research findings in a fully open access, online journal environment.